Physician
Silicon Valley Medical Imaging INC a Medical Corporation
Silicon Valley Medical Imaging INC a Medical Corporation was paid $3.65M by Medicaid between Jan 2018 and Nov 2024, across 61 billing codes. Its largest line is 78459, — 17% of everything it billed.
33Billing provider infoSILICON VALLEY MEDICAL IMAGING INC A MEDICAL CORPORATION
FREMONT, CA 94538
FREMONT, CA 94538
33aNPI1376730358assigned 10/03/2007
33bProvider typeNuclear Medicine Physician
28Total paid$3.65M
24GClaims33,074
24DCodes billed61
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Nuclear Medicine Physician providers in California
Rank by total paid#4 of 32
Median peer was paid$140K
This provider vs. median26×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,870 | $2.31M | |
| 2019 | 8,537 | $874K | |
| 2020 | 1,665 | $41K | |
| 2021 | 2,987 | $108K | |
| 2022 | 2,850 | $121K | |
| 2023 | 2,697 | $145K | |
| 2024incomplete | 1,468 | $55K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 78459 | 17% | 303 | 279 | $639K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 11% | 1,394 | 1,354 | $403K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 8.0% | 1,855 | 1,688 | $293K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 6.3% | 277 | 254 | $229K |
| 93970 | 5.0% | 1,237 | 1,172 | $184K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.3% | 6,723 | 6,097 | $155K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 4.2% | 1,397 | 1,312 | $155K |
| 93880 | 4.2% | 1,210 | 1,137 | $152K | |
| J2785 | Injection, regadenoson, 0.1 mg | 3.9% | 957 | 930 | $143K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3.7% | 4,485 | 4,003 | $136K |
| 93925 | 3.6% | 990 | 903 | $132K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 3.5% | 1,327 | 1,286 | $128K |
49 more codes
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 3.3% | 515 | $122K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 2.2% | 351 | $79K |
| 93015 | 2.0% | 2,226 | $73K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1.9% | 555 | $71K |
| 93886 | 1.9% | 425 | $71K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 1.9% | 517 | $70K |
| 76770 | 1.9% | 584 | $69K | |
| 72141 | 1.6% | 216 | $57K | |
| 93923 | 1.3% | 644 | $48K | |
| 93931 | 1.2% | 642 | $45K | |
| 73221 | <1% | 145 | $36K | |
| 78608 | <1% | 266 | $28K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 96 | $22K |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | <1% | 142 | $22K |
| 36475 | <1% | 13 | $12K | |
| 93892 | <1% | 46 | $10K | |
| 93890 | <1% | 46 | $10K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,126 | $9K |
| 78814 | <1% | 14 | $7K | |
| 78492 | <1% | 119 | $7K | |
| J0280 | Injection, aminophyllin, up to 250 mg | <1% | 1,068 | $5K |
| 70544 | <1% | 188 | $5K | |
| 74178 | <1% | 13 | $5K | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 68 | $5K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 40 | $4K |
| 70547 | <1% | 100 | $2K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 15 | $2K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 80 | $2K |
| 77002 | <1% | 13 | $1K | |
| 99243 | <1% | 14 | $1K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 26 | $1K |
| 71250 | <1% | 132 | $959.81 | |
| 72040 | <1% | 15 | $698.25 | |
| 72100 | <1% | 13 | $554.53 | |
| 78431 | <1% | 106 | $472.73 | |
| 78320 | <1% | 12 | $404.63 | |
| 78803 | <1% | 27 | $374.01 | |
| 75574 | <1% | 16 | $360.19 | |
| 78607 | <1% | 28 | $343.38 | |
| 73706 | <1% | 30 | $301.31 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 12 | $180.75 |
| 78434 | <1% | 57 | $135.83 | |
| 76706 | <1% | 12 | $85.45 | |
| 70498 | <1% | 15 | $38.91 | |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | <1% | 12 | $25.02 |
| 70496 | <1% | 16 | $14.33 | |
| J1245 | Injection, dipyridamole, per 10 mg | <1% | 22 | $4.96 |
| A9584 | Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries | 0% | 66 | $0.00 |
| 74174 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHANDAK, PUNEET (CEO / PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Beverly Hills Medical Imaging | Beverly Hills, CA | $115K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.